Molecular recogntion assays of critical structure attributes in proteoforms
AssigneeNovilytic, LLC
InventorsFred Regnier, Jinhee Kim, Meena Narsimhan, Nathan Morris, Mary Bower
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovilytic, LLC
InventorsFred Regnier, Jinhee Kim, Meena Narsimhan, Nathan Morris, Mary Bower
Estimating the term…
A method is provided to simultaneously identify and quantify critical structure attributes (CSAs) in proteoforms or proteoform families that includes the steps of: 1. injecting a sample into a reagent stream of one or more detection enhanced molecular recognition reagents; 2. incubating the combined sample:reagent(s) during migration through an analytical platform the causes molecular recognition reagent(s) to be sequestered by a specific critical structure attribute (CSA) in the analyte to form a luminon (An:*Sas) complex; 3. using a sequestron selector in the reagent stream to overtake the luminon complex in a down-stream size exclusion chromatography (SEC) column to achieve mixing and formation of an Nc˜Pas:An:*Sas, Pas:An:*Sas, or *Pas:An:*Sas sequestome complex; 4. resolving this sequestome complex from any unbound affinity selector(s) such as *Sas or *Pas, and non-analytes in the SEC column; 5. transporting the resolved sequestome complex into a flow-through detection means that detects and quantifies CSAs in fluorescent labeled *Sas or *Pas bearing luminon or sequestome complex to generate data for the construction of critical structure attribute ratio plots as a function of elapsed fermentation time.
A method for simultaneously identifying and quantifying critical structure attributes (CSAs) in a proteoform or proteoform family using an analytical platform comprising the steps of:
A luminon assay method for analyzing a critical structure attribute in a proteoform or proteoform family through sequestration of one or more affinity selectors, comprising the steps of:
A method for in-line monitoring of one or more critical structure attributes (CSAs) in a proteoform or proteoform family by analyte sequestering of affinity selectors, comprising the steps of:
Dependencies are inferred from the claim text.